Equities analysts expect Clorox Co (NYSE:CLX) to post sales of $1.69 billion for the current fiscal quarter, according to Zacks Investment Research. Five analysts have issued estimates for Clorox’s earnings, with estimates ranging from $1.69 billion to $1.71 billion. Clorox also posted sales of $1.69 billion in the same quarter last year. The company is scheduled to report its next quarterly earnings report on Thursday, August 1st.

On average, analysts expect that Clorox will report full-year sales of $6.28 billion for the current financial year, with estimates ranging from $6.27 billion to $6.29 billion. For the next financial year, analysts expect that the business will post sales of $6.41 billion, with estimates ranging from $6.39 billion to $6.44 billion. Zacks Investment Research’s sales calculations are a mean average based on a survey of research firms that that provide coverage for Clorox.

Clorox (NYSE:CLX) last issued its quarterly earnings data on Wednesday, May 1st. The company reported $1.44 earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of $1.47 by ($0.03). The firm had revenue of $1.55 billion for the quarter, compared to analysts’ expectations of $1.57 billion. Clorox had a return on equity of 108.82% and a net margin of 12.68%. The firm’s revenue was up 2.2% on a year-over-year basis. During the same period last year, the company earned $1.37 earnings per share.

Several analysts have recently issued reports on CLX shares. Zacks Investment Research cut Clorox from a “hold” rating to a “sell” rating in a report on Tuesday, April 16th. Bank of America reaffirmed a “neutral” rating and set a $154.00 price objective (down from $165.00) on shares of Clorox in a report on Thursday, May 2nd. JPMorgan Chase & Co. cut Clorox from a “neutral” rating to an “underweight” rating and decreased their price objective for the stock from $159.00 to $139.00 in a report on Monday, April 8th. Citigroup set a $156.00 price objective on Clorox and gave the stock a “hold” rating in a report on Thursday, May 23rd. Finally, Credit Suisse Group started coverage on Clorox in a report on Wednesday, March 6th. They set an “outperform” rating and a $172.00 price objective on the stock. Four equities research analysts have rated the stock with a sell rating, eight have issued a hold rating and three have given a buy rating to the company’s stock. Clorox currently has a consensus rating of “Hold” and an average price target of $149.29.

In related news, SVP Denise Garner sold 20,399 shares of the stock in a transaction on Friday, June 7th. The stock was sold at an average price of $157.61, for a total transaction of $3,215,086.39. Following the sale, the senior vice president now owns 4,896 shares in the company, valued at approximately $771,658.56. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Corporate insiders own 1.40% of the company’s stock.

A number of large investors have recently added to or reduced their stakes in CLX. Athena Capital Advisors LLC purchased a new stake in Clorox in the fourth quarter worth $25,000. Zions Bancorporation N.A. purchased a new stake in Clorox in the first quarter worth $28,000. Northstar Capital Management LLC purchased a new stake in Clorox in the first quarter worth $29,000. Capital Financial Planning LLC purchased a new stake in Clorox in the fourth quarter worth $32,000. Finally, Paragon Capital Management LLC purchased a new stake in Clorox in the first quarter worth $35,000. Institutional investors own 77.67% of the company’s stock.

Shares of CLX traded up $0.97 during mid-day trading on Friday, hitting $157.10. 21,136 shares of the stock were exchanged, compared to its average volume of 1,046,250. The stock has a market capitalization of $19.89 billion, a price-to-earnings ratio of 25.10, a price-to-earnings-growth ratio of 4.56 and a beta of 0.38. Clorox has a 52-week low of $125.40 and a 52-week high of $167.70. The company has a debt-to-equity ratio of 2.93, a current ratio of 1.10 and a quick ratio of 0.66.

The business also recently declared a quarterly dividend, which will be paid on Friday, August 16th. Investors of record on Wednesday, July 31st will be issued a dividend of $1.06 per share. This represents a $4.24 annualized dividend and a yield of 2.70%. The ex-dividend date is Tuesday, July 30th. This is a positive change from Clorox’s previous quarterly dividend of $0.96. Clorox’s dividend payout ratio is presently 61.34%.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Cleaning, Household, Lifestyle, and International. The company offers laundry additives, including bleach products under the Clorox brand, as well as Clorox 2 stain fighter and color booster; home care products primarily under the Clorox, Formula 409, Liquid-Plumr, Pine-Sol, S.O.S, and Tilex brands; naturally derived products under the Green Works brand; and professional cleaning, disinfecting, and food service products under the Clorox, Dispatch, HealthLink, Clorox Healthcare, Hidden Valley, KC Masterpiece, and Soy Vay brands.

Recommended Story: The components of the Stochastic Momentum Index

Get a free copy of the Zacks research report on Clorox (CLX)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.